Critics, however, worry that businesses are getting ahead of scientific data. The tests still aren't cheap, either, running several hundred dollars depending on the number of biomarkers or genes tested. In the case of blood tests, which most companies suggest repeating several times a year, it's an ongoing investment, too.
His smelling machine uses an array of sensors composed of gold nanoparticles or carbon nanotubes. They are coated with ligands, molecular receptors that have a high affinity for certain biomarkers of disease found in exhaled breath.
The analysis focuses on blood biomarkers, which are chemicals whose presence or amount may indicate abnormal processes or reactions in the body. Among the most familiar are cardiovascular ones: high- and low-density lipoproteins (HDL and LDL, the good and bad cholesterols) and triglycerides.
Finding individual differences in tumors is key to treating the right patient with the right medicine at the right time, researchers say.
Novel biomarkers are the subject of intense controversy, with a bewildering variety of factions and perspectives seeking to elevate or dismiss any of a large number of proposed new measures. Now a new examination of the literature published online in JAMA Internal Medicine suggests that the evidence base used to evaluate novel biomarkers may be seriously compromised by selective reporting bias.
Google Inc. has embarked on what may be its most ambitious and difficult science project ever: a quest inside the human body.
Called Baseline Study, the project will collect anonymous genetic and molecular information from 175 people—and later thousands more—to create what the company hopes will be the fullest picture of what a healthy human being should be.
To cut through some of the mystery of mental disorders, universities and medical-technology companies are seeking firmer biological clues that may be lurking in blood and saliva--so-called biomarkers.
Your age may really just be a number: How well you’re aging may be better revealed by a pattern of chemicals found in your blood than by that number. Indeed, a new study finds that certain “biomarker signatures” in the blood can signal people’s risk of later developing some age-related health conditions.
Physicians need more than the question: “How many fingers am I holding up?”
Researchers found there’s little correlation between a woman’s “ovarian reserve” test and her chances of getting pregnant.
Two recent FDA drug approvals point to an encouraging future for “precision medicine” — an approach for disease treatment that tailors medical therapies, including medications, to the needs of individual patients. These approvals involve diseases resulting from particular genetic characteristics identified by laboratory testing.
According to Biophysical Corporation, the 250 biochemical markers measured by its assay provide information about a broad range of the body’s organic systems and their state of function. The biomarkers can be accordingly assigned to different categories; some fit into several groupings simultaneously because those molecules play multiple important roles in sickness and health.
Modern technology could do a better job of picking up health problems before they get out of hand.
BiomarkerBay is a service concept that brings together academic expertise and contract research organizations to provide integrated services for the validation, bioanalysis and clinical testing of novel biomarkers and companion diagnostics.
The journal Biomarkers brings together all aspects of the rapidly growing field of biomarker research, encompassing their various uses and applications in one essential source. Biomarkers provides a vital forum for the exchange of ideas and concepts in all areas of biomarker research.
In addition to the full conference agenda, this event offers you the chance to meet face-to-face with leading industry solution providers and senior-level industry peers through a series of formal and informal networking opportunities.
The Biomarkers Consortium is a major public-private biomedical research partnership managed by the Foundation for the National Institutes of Health (FNIH) with broad participation from stakeholders across the health field, including government, industry, academia and patient advocacy and other not-for-profit organizations.
Biomarkers in Medicine (ISSN: 1752-0363) is a peer-reviewed, rapid publication journal delivering commentary and analysis on the advances in our understanding of biomarkers and their potential and actual applications in medicine. The journal facilitates translation of our research knowledge into the clinic to increase the effectiveness of medical practice.
Journal of Biomarkers is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies in all areas of biomarkers.
Journal of Molecular Biomarkers and Diagnosis is a broad-based journal found on two key tenets: To publish the most exciting Reviews on Molecular Biomarkers and diagnosis: Second to provide a rapid turn-around time possible for reviewing and publishing of articles freely for research, teaching and reference purposes.
Finding new preclinical biomarkers for research or clinical biomarkers for personalized treatments and companion diagnostics.